Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection

The self-reported personal wellbeing of a sample of Australian injecting drug users

(2010) Paul Dietze et al.   ADDICTION

Barriers to accessing care in patients with chronic hepatitis C: the impact of depression

(2010) D. M. Evon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

(2010) Jason Grebely et al.   JOURNAL OF HEPATOLOGY

Mental Health Symptoms Among Street-Based Psychostimulant Injectors in Sydney's Kings Cross

(2010) Libby Topp et al.   SUBSTANCE USE & MISUSE

Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C

(2009) F. SCHMIDT et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prospective Analysis of Depression During Peginterferon and Ribavirin Therapy of Chronic Hepatitis C: Results of the Virahep-C Study

(2009) Donna M Evon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence

(2009) Margaret Hellard et al.   CLINICAL INFECTIOUS DISEASES

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study

(2009) J. Grebely et al.   DRUG AND ALCOHOL DEPENDENCE

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

(2009) Gregory J. Dore et al.   GASTROENTEROLOGY

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

(2008) Michael Maes et al.   METABOLIC BRAIN DISEASE